1312797-14-0
Chemical Structure
Parsatuzumab
Synonym(s): Anti-EGFL7; RG 7414
- CAS No.: 1312797-14-0
- Formula:N/A
- Molecular Weight:(148.22 kDa)
IUPAC Name: (S)-4-(((4S,7S,8S)-7-carbamoyl-1-guanidino-8-methyl-5-oxodecan-4-yl)amino)-3-((S)-2-((2S,4R)-1-(((R)-5-(dimethylamino)-2-((S)-2-((S)-1-octanoylpiperidine-3-carboxamido)-3-phenylpropanamido)pentanoyl)-L-leucyl)-4-hydroxy-N-methylpyrrolidine-2-carboxamido)-4-methylpentanamido)-4-oxobutanoic acid hydrochloride
SMILES: [Parsatuzumab]
Biological Activity: Parsatuzumab (Anti-EGFL7; RG 7414) is a humanized monoclonal antibody, acts as an immunomodulator and binds to EGFL7. Parsatuzumab selectively blocks the interaction between EGFL7 and endothelial cells, potentially inhibiting vascular regrowth and reducing vascular endothelial growth factor (VEGF) inhibition[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Parsatuzumab | 97.40% | Parsatuzumab (Anti-EGFL7; RG 7414) is a humanized monoclonal antibody, acts as an immunomodulator and binds to EGFL7. Parsatuzumab selectively blocks the interaction between EGFL7 and endothelial cells, potentially inhibiting vascular regrowth and reducing vascular endothelial growth factor (VEGF) inhibition. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
